IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Euro Chemo-Pharma Sdn. Bhd. on May 18, 2023. In this transaction, IMCD will also acquire Euro Chemo-Pharma's wholly owned subsidiary, Biofresh Green Sdn Bhd. Euro Chemo-Pharma has reported revenue of approximately MYR 270 million during financial year ended on June 30, 2022. The closing of the transaction is subject to customary closing conditions. The transaction is expected to take place in the last quarter of 2023.

IMCD N.V. (ENXTAM:IMCD) completed the acquisition of Euro Chemo-Pharma Sdn. Bhd. on February 29, 2024.